NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 7 analysts with an average price target of $13.63. This is a potential upside of $4.27 (45.62%) from yesterday's end of day stock price of $9.36.

Neuropace's activity chart (see below) currently has 37 price targets and 42 ratings on display. The stock rating distribution of NPCE is 14.29% HOLD and 85.71% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56% with an average time for these price targets to be met of 125.86 days.

Highest price target for NPCE is $17, Lowest price target is $15, average price target is $17.6.

Most recent stock forecast was given by VIK CHOPRA from WELLS FARGO on 13-Aug-2025. First documented stock forecast 17-May-2021.

Currently out of the existing stock ratings of NPCE, 3 are a HOLD (14.29%), 18 are a BUY (85.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$5.85 (63.93%)

$13

21 days ago
(13-Aug-2025)

2/3 (66.67%)

$5.68 (60.94%)

171

Buy

$16

$6.85 (74.86%)

$14

3 months 20 days ago
(14-May-2025)

4/5 (80%)

$0.4 (2.56%)

127

Buy

$17

$7.85 (85.79%)

$20

3 months 20 days ago
(14-May-2025)

4/5 (80%)

$1.4 (8.97%)

179

Buy

$20

$10.85 (118.58%)

$20

1 years 3 months 28 days ago
(06-May-2024)

3/5 (60%)

$6.53 (48.48%)

121

Buy

$20

$10.85 (118.58%)

$16

1 years 5 months 20 days ago
(14-Mar-2024)

5/8 (62.5%)

$6.37 (46.74%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 125.86 days on average for the stock forecasts to be realized with a an average price target met ratio 56

Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?

ROSS OSBORN

Which analyst has the current lower performing score on NPCE (Neuropace) with a proven track record?

MIKE POLARK

Which analyst has the most public recommendations on NPCE (Neuropace)?

Ross Osborn works at CANTOR FITZGERALD and has 9 price targets and 7 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Mike Polark with highest potential upside - $11.39

Which analyst is the currently most reserved on NPCE (Neuropace)?

Drew Ranieri with lowest potential downside - $1.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?